Influenza, Human  >>  Rebif (human IFN-β-1a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rebif (human IFN-β-1a) / EMD Serono
RELIEF, NCT02064816 / 2013-004450-21: A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis

Completed
4
200
Europe
Rebif®
Merck KGaA, Darmstadt, Germany
Multiple Sclerosis, Relapsing-Remitting
04/16
04/16
Frequency, NCT02234869: Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy

Withdrawn
4
0
US
Interferon Beta, Rebif or Betaseron/Betaferon, BIIB017 (Peginterferon beta-1a), PEGylated interferon beta-1a (IFN β-1a)
Biogen
Relapsing Multiple Sclerosis
02/17
03/18

Download Options